|
Sign In to gain access to subscriptions and/or personal tools.
|
Progesterone, Estrogens, and their Receptors in Breast Cancers KATHRYN B. HORWITZ, Departments of Medicine, Pathology and the Molecular Biology Program, University of Colorado School of Medicine, Denver, Colorado
References
- Hopp, T.A., H.L. Weiss, V.-J. Bardou, S.G. Hilsenbeck, D.C. Allred, K.B. Horwitz, and S.A.W. Fuqua (Submitted). "Progesterone Receptor (PR) A and B in Breast Cancer: PR-A Rich Tumors Have Poorer Disease Free Survival."
- Jacobsen, B.M., S. Schittone, J.K. Richer, and K.B. Horwitz (2002). "Construction of New Breast Cancer Cell Lines with Inducible Progesterone A-and B-Receptors: Ligand Independent Effects and Isoform Ratios. J Biol Chem 277(31): 27793—800.[Abstract/Free Full Text]
- Richer, J.K., B.M. Jacobsen, N.G. Manning, M.G. Abel, D.M. Wolf, and K.B. Horwitz (2002). "Differential Gene Regulation by the two Progesterone Receptor Isoforms in Human Breast Cancer Cells." J Biol Chem 277(7): 5209—18.[Abstract/Free Full Text]
- Sartorius, C.A., T. Shen, and K.B. Horwitz (2003). "Progesterone A Receptors Repress the Growth of Estrogen-Dependent Human Breast Tumor Xenografts." Breast Cancer Res and Treatment 79: 287—99.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Tung, L., C.A. Sartorius, M.G. Abel, T. Shen, G.S. Takimoto, and K.B. Horwitz (2001). "Mapping the Progesterone B-receptor N-terminal Upstream Segment (BUS) Involved in Activation Function-3. Two LXXLL Motifs and a Conserved Tryptophan are Required for Activity." J Biol Chem 276(43): 39843—51.[Abstract/Free Full Text]
Toxicologic Pathology, Vol. 32, No. 1,
142-143 (2004)
DOI: 10.1080/714592166

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|